Page last updated: 2024-08-21

diphenylamine and Hypopharyngeal Neoplasms

diphenylamine has been researched along with Hypopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiao, W; Jin, M; Kong, D; Li, H; Lin, P; Liu, Y; Peng, X; Qiu, Y; Wang, R; Zhang, Z; Zhu, S	1

Other Studies

1 other study(ies) available for diphenylamine and Hypopharyngeal Neoplasms

Article	Year
Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma. Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:12 Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diphenylamine; Drug Synergism; Humans; Hypopharyngeal Neoplasms; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Retrospective Studies; Signal Transduction; Sulfonamides	2019

Article

Year

Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.

Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:12

Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diphenylamine; Drug Synergism; Humans; Hypopharyngeal Neoplasms; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Retrospective Studies; Signal Transduction; Sulfonamides

2019